Clinical Trials for Renal Allograft Recipients

A Study to Evaluate the Benefits and Risks of Conversion of Existing Adolescent Kidney Transplant Recipients Aged 12 to <18 Years to a Belatacept-based Immunosuppressive Regimen as Compared to Continuation of a Calcineurin Inhibitor-based Regimen, and Their Adherence to Immunosuppressive Medications

NCT ID: NCT04877288

This clinical trial is looking at how well a new medication called belatacept works for teenagers aged 12 to under 18 who have received a kidney transplant. The study compares the effects of switch...